Application 021484
- Type
- BLA
- Sponsor
- FERRING
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BRAVELLE | UROFOLLITROPIN | Injectable; Subcutaneous | 0.9% | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.